-
Product Insights
Plaque Psoriasis (Psoriasis Vulgaris) – Drugs In Development, 2023
Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Drugs In Development, 2023’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Plaque Psoriasis (Psoriasis Vulgaris), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Overview The Plaque Psoriasis (Psoriasis Vulgaris) clinical trial report consists of 2018 trials. The report provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) clinical trial scenario. Our study also includes top-line data relating to the clinical trials on Plaque Psoriasis (Psoriasis Vulgaris). Our analysts have further provided an overview of trial numbers and their average enrolment in top countries conducted across the globe, in this report. Furthermore, our review of the Plaque Psoriasis...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.